TRVX.OL Current Ratio

As of 2025-05-20, the Current Ratio of Targovax ASA (TRVX.OL) is 2.33.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

TRVX.OL Current Ratio - Historical Value

Date	Value
2022-12-31	2.33
2021-12-31	5.11
2020-12-31	4.96
2019-12-31	1.69
2018-12-31	2.8
2017-12-31	9.76
2016-12-31	6.37
2015-12-31	7.3
2014-12-31	10.07
	-

TRVX.OL Current Ratio - Peers Comparison

Ticker	Name	Value
ACTI.ST	Active Biotech AB publ	4.4
ADOC.PA	Adocia SA	1.08
AEGIR.ST	Aegirbio AB	1.64
ALHYG.PA	Hybrigenics SA	1.71
ALLR.ST	Allarity Therapeutics A/S	0.4
ALNEV.PA	Neovacs SA	1.03
ALNOX.PA	Noxxon Pharma NV	1.84
ALPAT.PA	Plant Advanced Technologies PAT SA	2.11
ALPRE.PA	Predilife SA	3.22
ATORX.ST	Alligator Bioscience AB	0.35
AZT.OL	Arcticzymes Technologies ASA	17.12
BGBIO.OL	Bergenbio ASA	4.79
EGTX.ST	Egetis Therapeutics AB (publ)	1.86
ETX.L	E-Therapeutics PLC	21.3
EVG.L	Evgen Pharma PLC	7.36
EXTX.OL	Exact Therapeutics AS	3.61
GNRO.PA	Geneuro SA	0.37
GUARD.ST	Guard Therapeutics International AB (publ)	3.14
GV.PA	Genomic Vision SA	0.91
HBC.OL	Hofseth Biocare ASA	0.52
KURN.SW	Kuros Biosciences AG	2.14
LIDDS.ST	Lidds AB	4.86
LYTIX.OL	Lytix Biopharma AS	3.91
MDG1.DE	Medigene AG	2.53
MDXH.BR	MDxHealth SA	1.59
MVIR B.ST	Medivir AB	4.39
NANOV.OL	Nordic Nanovector ASA	2.46
OXUR.BR	Oxurion NV	0.22
PCIB.OL	PCI Biotech Holding ASA	3.98
PUR.WA	Pure Biologics SA	2.6
RENE.L	ReNeuron Group PLC	2.05
SENZA.ST	SenzaGen AB	2.66
T5O.DE	bioXXmed AG	44.34
ULTI.OL	Ultimovacs ASA	4.85
VACC.OL	Vaccibody AS	17.38
VSC.DE	4Sc AG	5.51